For instance, in bladder cancer, GSTM5 overexpression has been linked to reduced cell proliferation, migration, and colony formation [21], while in lung adenocarcinoma, aberrant GSTM5 expression correlates with poor overall survival [22]. Here, GSTM5 is linked to urinary bladder cancer.